Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of CKD-843 in Male Volunteers
NCT04805606Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dutasteride in androgenetic alopecia (AGA) (5 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration up to 90 days, Area Under the Concentration-Time Curve From Time Zero to Infinity at Day 1 and 1 more. Started Apr 2021; status: completed.
02
Drugs
dutasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT04805606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04805606.